Nan Ya PCB Corp (南亞電路), the nation's third-largest manufacturer of printed circuit boards, drew a huge number of subscribers to its initial public offering (IPO) on the first two days, following in the footsteps of E-ton Solar Tech Co (益通光能), which made its debut earlier this month.
A subsidiary of the Formosa Plastics Group (台塑集團), Nan Ya PCB is offering 6.8 million shares at NT$250 (US$7.65) per share to the public through a lot drawing system from Thursday until April 3.
The company will hold the lot drawing on April 5, and make its debut on the Taiwan Stock Exchange on April 7.
Shares of Nan Ya PCB weakened by 1.77 percent to close at NT$290 on the Emerging Stock Market (興櫃市場) yesterday. The stock's highest price was NT$336 last Tuesday.
As the average price of Nan Ya PCB is NT$300, investors can expect an immediate return of NT$50,000 if they win the lot drawing.
Despite the reward not being as high as in the case of E-ton's IPO, from which investors earned more than NT$600,000, Nan Ya PCB has lured 62,563 subscriptions on the first two days of its IPO, according to figures released yesterday by the Taiwan Stock Exchange.
"Investors may tend to make quick pocket money from the IPO, especially after the lackluster performance of the stock market this week," said Stanley Yeh (
The hype may boost Nan Ya PCB's share price after the debut, but the winning streak may not last long, Yeh said.
Nan Ya PCB posted NT$24.17 billion (US$742.9 million) in sales last year, with after-tax earnings amounting to NT$4.05 billion, or NT$7.75 per share.
The results may seem rosy, but the company did not start making money until the second half of the year, Yeh said.
Nan Ya PCB obtained more orders of flip-chip (FC) substrates -- a printed circuit board used in high-end electronic products -- after stronger rival Advanced Semiconductor Engineering Inc's (ASE, 日月光) production was cut by a fire in its Chungli (中壢) factory in Taoyuan County last May.
As production at ASE has been stabilizing, along with capacity expansion of rivals such as Kinsus Interconnect Technology Corp (景碩科技), the supply of FC substrates will not be as tight as it was last year, which will further drive down prices, Yeh said.
Eric Lai (賴建承), an analyst at Marbo Securities Consultant Co (萬寶證券投資顧問), held a positive view on the stock owing to the strong demand for FC substrates.
Nan Ya PCB's clients include the world's largest chipmaker, Intel Corp, which has a large demand for FC substrates to be used in its dual-core central processing units. Another boost will come from Sony's PlayStation 3 game consoles.
As a result, some market watchers expect Nan Ya PCB to earn more than NT$25 per share this year, but Lai said that a more moderate outlook should fall between NT$13 to NT$15 per share.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining